C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2011
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275624 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
11/10/2011	US20110275623 Bi-functional pyrazolopyridine compounds
11/10/2011	US20110275622 Bi-functional quinoline analogs
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275610 Substituted pyrazole compounds
11/10/2011	US20110275608 Piperidine-containing compounds and use thereof
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274648 Hepatitis C Virus Inhibitors
11/10/2011	US20110272681 Light-emitting element material and light-emitting element
11/10/2011	US20110272676 Benzimidazole compound organic photoelectric device including the same, and display element including the same
11/09/2011	EP2385052A1 Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device
11/09/2011	EP2385051A1 Process for making a substituted oxazole
11/09/2011	EP2385050A1 A process for preparing a substituted oxazole
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP2385040A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011	EP2384320A2 Pyrrolidine compounds which modulate the cb2 receptor
11/09/2011	EP2139881B1 Quinolines and their therapeutic use
11/09/2011	EP2066647B1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
11/09/2011	EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011	EP1789390B1 Pyridyl inhibitors of hedgehog signalling
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011	EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011	CN1882542B 2-pyridone derivatives as neutrophil elastase inhibitors and their use
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239160A Substituted (pyridyl)-azinylamine derivatives as fungicides
11/09/2011	CN102239152A Novel amide derivative and use thereof as medicine
11/09/2011	CN102239146A Novel compounds as calcium channel blockers
11/09/2011	CN102234270A Diarylurea derivatives and treatment application thereof
11/09/2011	CN101643456B Synthesis method of symmetric 1, 3, 4-oxadiazole
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101048402B Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	US8053434 Kinase inhibitors and their uses
11/08/2011	CA2529126C Azetidine compounds
11/08/2011	CA2509982C N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
11/08/2011	CA2460572C Dual action antibiotics
11/08/2011	CA2405408C Pyrazole compounds
11/03/2011	WO2011137222A1 Processes for preparing linezolid
11/03/2011	WO2011136927A1 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/03/2011	WO2011136723A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011	WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
11/03/2011	WO2011136307A1 Prophylactic or therapeutic agent for night urination
11/03/2011	WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011	WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011	WO2011134913A1 Fungicide hydroximoyl-heterocycles derivatives
11/03/2011	WO2011134912A1 Fungicide hydroximoyl-heterocycles derivatives
11/03/2011	WO2011134280A1 Compounds as agonists of s1p1 receptors
11/03/2011	WO2011134067A1 Novel amino acid molecule and uses thereof
11/03/2011	WO2010116282A8 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
11/03/2011	WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269960 Triazole derivative
11/03/2011	US20110269959 Process for the preparation of piperazine derivatives
11/03/2011	US20110269958 Pyridons as pdk1 inhibitors
11/03/2011	US20110269957 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
11/03/2011	US20110269956 Hepatitis C Virus Inhibitors
11/03/2011	US20110269955 Method for preparing 2-morpholinoisobornane- 10-thiol and intermediates formed therein
11/03/2011	US20110269954 Novel thiazolidinedione derivative and use thereof
11/03/2011	US20110269953 Nitrogen and Sulfur-Containing Heterocycle Derivatives
11/03/2011	US20110269804 Insecticidal compounds
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269765 Pyridazinone derivatives
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269756 Benzothiazolone derivatives
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269752 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269746 Cyclic compound having hetero atom
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269741 Novel compositions and methods of use
11/03/2011	US20110269739 Kinase inhibitors
11/03/2011	US20110269737 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases
11/03/2011	US20110269714 Polycyclic Tetracycline Compounds
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	CA2795218A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/02/2011	EP2383270A1 Piperidine GPCR agonists
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2383268A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
11/02/2011	EP2383263A2 Novel thiazolidinedione derivative and use thereof
11/02/2011	EP2382212A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382211A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
11/02/2011	EP2382210A2 Pyrimidinediamine kinase inhibitors
11/02/2011	EP2382209A1 Polymorphic form of 5-chloro-n-{ý(5s)-2-oxo-3-ý4-(3-oxomorpholin-4-yl)phenyl¨oxa-zolidin-5-yl¨-methyl}thiophene-2-carboxamide

1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 647